9606 (9606) News
Follow 9606 (9606) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Duality Biotherapeutics Says Phase 3 Breast Cancer Trial Met Primary Endpoint
Duality Biotherapeutics said its global DYNASTY-BREAST02 Phase 3 clinical trial met its primary endpoint.
EQUITY | Oct 26, 2026, 04:54 PM UTC
L
Tharwah H1 Net Loss 1.3 Million SAR
Tharwah H1 Net Loss 1.3 Million SAR
EQUITY | Aug 31, 2026, 06:13 AM UTC
M
Duality Biotherapeutics results: revenue down, loss narrowed, partnerships grow
Duality Biotherapeutics reported revenue fell on a one-off item, while its net loss narrowed and global partnerships expanded.
EQUITY | Aug 28, 2026, 10:42 AM UTC
L
Duality Biotherapeutics signs global R&D collaboration and license deal with Genentech
Duality Biotherapeutics said it has entered a global research and development collaboration and license agreement with Genentech.
EQUITY | Aug 28, 2026, 01:31 AM UTC